2BB score and signals
Aligos Therapeutics, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 15 | Very Low |
| Momentum | 30 | Weakening |
| Financial strength | 21 | Weak |
| Quality | 80 | Very Strong |
| Risk | 59 | Moderate |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2018 |
| Employees | 82 |
| 52-week range | $3.98 – $13.69 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | -2.4734 | — | $2.01M |
| 2026-08-06 | — | -1.095 | — | $18.61M |
| 2026-05-07 | -2.21 | -2.2675 | $2.83M | $510,000.00 |
| 2026-03-05 | -1.91 | -1.889 | $169,000.00 | $816,000.00 |
Related companies
2BBBullish & Bearish